How do you cite results from a product still in development in an EB-2 NIW petition?

In an EB-2 NIW petition, you can present preliminary results from a product still in development, as long as you are transparent about the research stage. The key is to demonstrate the merit and potential impact of your work without overstating what has not yet been proven.

The practical recommendation is to clearly signal that the data are preliminary. Accompany each projection or metric with an explanatory note indicating that the results come from initial tests, internal validations, or ongoing research. This transparency strengthens the rigor of your argument rather than weakening it.

To give weight to what you present, anchor the data in verifiable evidence:

• Technical reports and internal product validations.
• Publications, studies, or third-party opinions that support the results.
• Documentation showing the methodology and reproducibility of the tests.

Avoid promises of guaranteed results or marketing language, which undermine the credibility of your case. What strengthens a petition is consistency between what you claim and what the evidence supports. Since each case is evaluated individually, it is worth checking the updated guidance from the official source (USCIS) and reviewing your documentation strategy with a specialist.

About the author

Victoria Harper

Editor-in-Chief

Meet the author

As a journalist and lead editor at Visto n’ Visa, Victoria helps ensure that immigration topics are covered in a clear, trustworthy, and easy-to-understand way. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.